Natco Pharma Ltd. (NATCOPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 156274, "name": "Natco Pharma", "stock_name": "Natco Pharma", "full_name": "Natco Pharma Ltd.", "name_url": "stocks-analysis/natco-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "973.70", "chg": 23.95, "chgp": "2.52%", "dir": 1, "prev_price": "949.75", "mcapval": "17,521.00 Cr", "mcap": "Small Cap", "scripcode": 524816, "symbol": "NATCOPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE987B01026", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "7.38 lacs", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3908949", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_technicaldot_3908949.png", "date": "2026-03-24 08:00:17", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 10 March 2026, the stock’s price action and technical indicators suggest a cautiously optimistic outlook amid sector headwinds and market volatility." }, { "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3906134", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_mojoScore_3906134.png", "date": "2026-03-23 10:10:02", "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 March 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3906122", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_mojoScore_3906122.png", "date": "2026-03-22 10:10:03", "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 March 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date perspective on the company’s standing." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Monthly Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-monthly-indicators-3899530", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_technicaldot_3899530.png", "date": "2026-03-19 08:00:19", "description": "Natco Pharma Ltd. has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish stance to a more confident bullish trend. This change is underscored by improvements in moving averages, MACD, and RSI readings, suggesting renewed investor interest and potential upside in the pharmaceuticals and biotechnology sector." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3895514", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_technicaldot_3895514.png", "date": "2026-03-17 08:00:20", "description": "Natco Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The company’s recent downgrade from a Sell to a Hold rating, accompanied by a Mojo Score improvement to 57.0, highlights evolving market perceptions amid mixed technical indicators." }, { "title": "Natco Pharma Gains 3.14%: 2 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-gains-314-2-key-factors-driving-the-weeks-volatility-3892439", "imagepath": "", "date": "2026-03-15 16:01:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Significant gap down opening at Rs.820.35, intraday low</p>\n <p><strong>4 Mar:</strong> Continued weakness with a modest decline to Rs.952.80</p>\n <p><strong>5 Mar:</strong> Strong rebound with a 5.03% gain to Rs.1,000.70</p>\n <p><strong>6 Mar:</strong> Further gains of 1.86% closing at Rs.1,019.35</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.988.30</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,019.35</..." }, { "title": "Natco Pharma Falls 6.16%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-falls-616-3-key-factors-driving-the-weekly-decline-3891479", "imagepath": "", "date": "2026-03-14 16:04:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 9:</strong> Stock opens at ₹1,002.20 amid Sensex decline</p>\n <p><strong>Mar 10:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>Mar 11:</strong> Upgrade to Hold rating despite earnings setback</p>\n <p><strong>Mar 13:</strong> Sharp drop to ₹956.55 closes the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,019.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹956.55</div><div class=\"..." }, { "title": "Why is Natco Pharma Ltd. falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-natco-pharma-ltd-fallingrising-3890375", "imagepath": "", "date": "2026-03-14 01:15:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Natco Pharma's share price decline on 13-Mar was sharper than the sector's performance, underperforming by 4.07%. The stock touched an intraday low of ₹951.35, representing a 6.39% drop from previous levels. Trading volumes were concentrated near this low price, indicating selling pressure throughout the day. Despite this, the stock remains above its 20-day, 50-day, 100-day, and 200-day moving averages, though it slipped below the 5-day moving average, signalling short-term weakness.</p>\n<p>Investor participation also waned, with delivery volumes on 12-Mar falling by over 54% compared to the five-day average. This decline in active buying interest may have contributed to the downward pressure on the stock price. Liquidity remains adequ..." }, { "title": "Natco Pharma Upgraded to Hold as Technicals Improve Despite Recent Earnings Setback", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-upgraded-to-hold-as-technicals-improve-despite-recent-earnings-setback-3884507", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NatcoPharmaLtd_mojoScore_3884507.png", "date": "2026-03-11 08:09:50", "description": "Natco Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 March 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite recent financial headwinds. The upgrade is driven by a combination of enhanced technical trends, attractive valuation, stable financial fundamentals, and a mixed but improving quality outlook." } ], "total": 5627, "sid": "156274", "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274" }, "announcements": [ { "details": "Natco Pharma Limited has informed the Exchange regarding Investor Presentation Q2 FY 2019-2020", "source": "NSE", "caption": "Natco Pharma Limited - Investor Presentation", "datetime": "18-Nov-2019" }, { "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Commercial Manufacturing Operations begin in NATCO s Visakhapatnam Formulation Facility \".", "source": "NSE", "caption": "Natco Pharma Limited - Press Release", "datetime": "15-Nov-2019" }, { "details": "Natco Pharma Limited has informed the Exchange regarding a press release dated November 12, 2019, titled \"NATCO records INR 518.9 Crore consolidated revenue and INR 117.7 Crore of profit, after tax, for the Second Quarter, FY2019-20\".", "source": "NSE", "caption": "Natco Pharma Limited - Press Release", "datetime": "13-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26", "dt": "2026-02-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15", "dt": "2015-11-26", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Significant gap down opening at Rs.820.35, intraday low

4 Mar: Continued weakness with a modest decline to Rs.952.80

5 Mar: Strong rebound with a 5.03% gain to Rs.1,000.70

6 Mar: Further gains of 1.86% closing at Rs.1,019.35

Week Open

Rs.988.30

Week Close

Rs.1,019.35Read full news article

Natco Pharma Falls 6.16%: 3 Key Factors Driving the Weekly Decline

2026-03-14 16:04:44

Key Events This Week

Mar 9: Stock opens at ₹1,002.20 amid Sensex decline

Mar 10: Golden Cross formation signals potential bullish breakout

Mar 11: Upgrade to Hold rating despite earnings setback

Mar 13: Sharp drop to ₹956.55 closes the week

Read full news article

Why is Natco Pharma Ltd. falling/rising?

2026-03-14 01:15:13

Recent Price Movement and Market Context

Natco Pharma's share price decline on 13-Mar was sharper than the sector's performance, underperforming by 4.07%. The stock touched an intraday low of ₹951.35, representing a 6.39% drop from previous levels. Trading volumes were concentrated near this low price, indicating selling pressure throughout the day. Despite this, the stock remains above its 20-day, 50-day, 100-day, and 200-day moving averages, though it slipped below the 5-day moving average, signalling short-term weakness.

Investor participation also waned, with delivery volumes on 12-Mar falling by over 54% compared to the five-day average. This decline in active buying interest may have contributed to the downward pressure on the stock price. Liquidity remains adequ...

Read full news article

Natco Pharma Upgraded to Hold as Technicals Improve Despite Recent Earnings Setback

2026-03-11 08:09:50

Natco Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 March 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite recent financial headwinds. The upgrade is driven by a combination of enhanced technical trends, attractive valuation, stable financial fundamentals, and a mixed but improving quality outlook.

Read full news article

View All News